Immunome (IMNM) News Today $10.15 -1.05 (-9.38%) Closing price 09/25/2025 04:00 PM EasternExtended Trading$10.25 +0.10 (+0.99%) As of 09/25/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IMNM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Immunome (NASDAQ:IMNM) Stock Price Down 5.9% - Here's WhySeptember 25 at 1:10 PM | marketbeat.comImmunome (NASDAQ:IMNM) Coverage Initiated at The Goldman Sachs GroupSeptember 25 at 2:25 AM | americanbankingnews.comImmunome (NASDAQ:IMNM) Shares Up 8% - What's Next?September 23 at 4:38 PM | marketbeat.comImmunome stock a ‘buy' on ‘rich pipeline' of oncology therapeutics: analystsSeptember 23 at 4:07 PM | proactiveinvestors.comImmunome stock a ‘buy' on ‘rich pipeline' of oncology therapeutics: analystsSeptember 23 at 3:00 PM | proactiveinvestors.comImmunome (NASDAQ:IMNM) Upgraded to "Strong-Buy" at The Goldman Sachs GroupSeptember 23 at 6:23 AM | marketbeat.comImmunome initiated with a Buy at Goldman SachsSeptember 23 at 4:06 AM | msn.comGoldman Sachs Initiates Coverage of Immunome (IMNM) with Buy RecommendationSeptember 23 at 4:06 AM | msn.comGoldman Sachs Group Inc. Lowers Holdings in Immunome, Inc. $IMNMSeptember 21, 2025 | marketbeat.comImmunome (NASDAQ:IMNM) Shares Down 5.4% - What's Next?September 20, 2025 | marketbeat.comWedbush Reiterates Outperform Rating for Immunome (NASDAQ:IMNM)September 19, 2025 | marketbeat.comImmunome's (IMNM) "Outperform" Rating Reiterated at WedbushSeptember 19, 2025 | americanbankingnews.comInfinimmune Announces Research Collaboration with ImmunomeSeptember 18, 2025 | businesswire.comImmunome (NASDAQ:IMNM) Trading Up 6% - Time to Buy?September 14, 2025 | marketbeat.comImmunome, Inc. $IMNM Shares Acquired by Woodline Partners LPSeptember 14, 2025 | marketbeat.comZimmer Partners LP Takes $673,000 Position in Immunome, Inc. $IMNMSeptember 12, 2025 | marketbeat.comExome Asset Management LLC Invests $1.78 Million in Immunome, Inc. $IMNMSeptember 11, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Acquires 275,000 Shares of Immunome, Inc. $IMNMSeptember 9, 2025 | marketbeat.comGranahan Investment Management LLC Has $2.82 Million Stock Position in Immunome, Inc. $IMNMSeptember 8, 2025 | marketbeat.comWalleye Capital LLC Takes $250,000 Position in Immunome, Inc. $IMNMSeptember 7, 2025 | marketbeat.comEcoR1 Capital LLC Has $27.45 Million Stock Holdings in Immunome, Inc. $IMNMSeptember 6, 2025 | marketbeat.comCraig-Hallum Initiates Coverage of Immunome (IMNM) with Buy RecommendationSeptember 6, 2025 | msn.comImmunome initiated with a Buy at Craig-Hallum ahead of near-term catalystsSeptember 5, 2025 | msn.comImmunome Stock Rises After Craig-Hellum Initiates Coverage With $26 Price Target: Here’s Why The Analyst Sees An ‘Attractive Entry Point’September 5, 2025 | msn.comWhere Immunome Stands With AnalystsSeptember 5, 2025 | benzinga.comImmunome (NASDAQ:IMNM) Trading Up 6.3% - Still a Buy?September 5, 2025 | marketbeat.comImmunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 4, 2025 | businesswire.comImmunome, Inc. $IMNM Stock Position Lifted by Redmile Group LLCSeptember 4, 2025 | marketbeat.comImmunome to Present at the H.C. Wainwright 27th Annual Global Investment ConferenceSeptember 3, 2025 | businesswire.comImmunome, Inc. (NASDAQ:IMNM) Given Average Recommendation of "Buy" by AnalystsSeptember 3, 2025 | marketbeat.comDriehaus Capital Management LLC Invests $4.11 Million in Immunome, Inc. $IMNMSeptember 2, 2025 | marketbeat.comNuveen LLC Takes Position in Immunome, Inc. $IMNMSeptember 1, 2025 | marketbeat.comVelan Capital Investment Management LP Buys New Shares in Immunome, Inc. $IMNMAugust 31, 2025 | marketbeat.comImmunome, Inc. $IMNM Shares Bought by Charles Schwab Investment Management Inc.August 31, 2025 | marketbeat.comAlphaQuest LLC Increases Holdings in Immunome, Inc. $IMNMAugust 30, 2025 | marketbeat.comVanguard Group Inc. Acquires 1,303,753 Shares of Immunome, Inc. $IMNMAugust 30, 2025 | marketbeat.comSwiss National Bank Boosts Stake in Immunome, Inc. $IMNMAugust 29, 2025 | marketbeat.comGuggenheim Reaffirms Buy Rating for Immunome (NASDAQ:IMNM)August 27, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Has $50.84 Million Stake in Immunome, Inc. $IMNMAugust 25, 2025 | marketbeat.comPiper Sandler Sticks to Their Buy Rating for Immunome (IMNM)August 24, 2025 | theglobeandmail.comGuggenheim Reaffirms Their Buy Rating on Immunome (IMNM)August 24, 2025 | theglobeandmail.comEvercore ISI Group Initiates Coverage of Immunome (IMNM) with Outperform RecommendationAugust 23, 2025 | msn.comFox Run Management L.L.C. Acquires New Holdings in Immunome, Inc. $IMNMAugust 23, 2025 | marketbeat.comWedbush Reaffirms Their Buy Rating on Immunome (IMNM)August 22, 2025 | theglobeandmail.comImmunome initiated with an Outperform at Evercore ISIAugust 22, 2025 | msn.comFreestone Capital Holdings LLC Buys New Shares in Immunome, Inc. $IMNMAugust 21, 2025 | marketbeat.comQ1 Earnings Forecast for Immunome Issued By Lifesci CapitalAugust 12, 2025 | marketbeat.comImmunome: SpringWorks Buyout Informs The Potential Upside HereAugust 11, 2025 | seekingalpha.comResearch Analysts Offer Predictions for Immunome Q3 EarningsAugust 11, 2025 | marketbeat.comWedbush Comments on Immunome's Q3 Earnings (NASDAQ:IMNM)August 11, 2025 | marketbeat.com Get Immunome News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMNM Media Mentions By Week IMNM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMNM News Sentiment▼0.691.02▲Average Medical News Sentiment IMNM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMNM Articles This Week▼144▲IMNM Articles Average Week Get the Latest News and Ratings for IMNM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Immunome and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CRNX News Today AMRX News Today CNTA News Today NAMS News Today HCM News Today SRRK News Today APLS News Today VKTX News Today MOR News Today XENE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMNM) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunome, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunome With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMNM Stock Alerts